Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.

Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N.

Am J Clin Oncol. 2014 Jan 7. [Epub ahead of print]

PMID:
24401670
[PubMed - as supplied by publisher]
2.

Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.

Koutcher L, Sherman E, Fury M, Wolden S, Zhang Z, Mo Q, Stewart L, Schupak K, Gelblum D, Wong R, Kraus D, Shah J, Zelefsky M, Pfister D, Lee N.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):915-22. doi: 10.1016/j.ijrobp.2010.07.008. Epub 2010 Oct 13.

PMID:
20947269
[PubMed - indexed for MEDLINE]
3.

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.

Argiris A, Heron DE, Smith RP, Kim S, Gibson MK, Lai SY, Branstetter BF, Posluszny DM, Wang L, Seethala RR, Dacic S, Gooding W, Grandis JR, Johnson JT, Ferris RL.

J Clin Oncol. 2010 Dec 20;28(36):5294-300. doi: 10.1200/JCO.2010.30.6423. Epub 2010 Nov 15.

PMID:
21079141
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.

Geiger JL, Lazim AF, Walsh FJ, Foote RL, Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI, Ma DJ, Neben-Wittich MA, Molina JR, Garcia JJ, Price KA.

Oral Oncol. 2014 Apr;50(4):311-8. doi: 10.1016/j.oraloncology.2014.01.001. Epub 2014 Jan 24.

PMID:
24467937
[PubMed - in process]
5.
6.

Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors.

Krstevska V, Stojkovski I, Zafirova-Ivanovska B.

Radiat Oncol. 2012 May 28;7:78. doi: 10.1186/1748-717X-7-78.

PMID:
22640662
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[Adjuvant chemotherapy (nedaplatin/UFT) after concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma].

Kubota A, Furukawa M, Komatsu M, Hanamura H, Sugiyama M.

Nihon Jibiinkoka Gakkai Kaiho. 2006 Mar 20;109(3):149-56. Japanese.

PMID:
16615429
[PubMed - indexed for MEDLINE]
8.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, Wacha J, Bayouth JE, Funk GF, Smith RB, Graham SM, Chang K, Hoffman HT.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):410-21.

PMID:
16168834
[PubMed - indexed for MEDLINE]
9.

Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.

Gupta T, Agarwal JP, Ghosh-Laskar S, Parikh PM, D'Cruz AK, Dinshaw KA.

Head Neck Oncol. 2009 Jun 15;1:17. doi: 10.1186/1758-3284-1-17.

PMID:
19527507
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: Ready for routine clinical practice?

Agarwal JP, Gupta T, Kalyani N, Budrukkar A, Laskar SG, Murthy V, Kumar P, Narohna V, Pai P, Chaturvedi P, D'cruz AK.

Indian J Cancer. 2011 Apr-Jun;48(2):148-53. doi: 10.4103/0019-509X.82872.

PMID:
21768657
[PubMed - indexed for MEDLINE]
Free Article
11.

Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.

Jeremic B, Milicic B, Dagovic A, Vaskovic Z, Tadic L.

J Clin Oncol. 2004 Sep 1;22(17):3540-8.

PMID:
15337803
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.

Oral Oncol. 2006 Aug;42(7):675-84. Epub 2006 May 30.

PMID:
16731029
[PubMed - indexed for MEDLINE]
14.

Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.

Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R; Head and Neck Cancer Disease Site Group.

Curr Oncol. 2010 Jun;17(3):37-48.

PMID:
20567625
[PubMed]
Free PMC Article
15.

Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.

Tang C, Chan C, Jiang W, Murphy JD, von Eyben R, Colevas AD, Pinto H, Lee-Enriquez N, Kong C, Le QT.

Head Neck. 2014 Jan 15. doi: 10.1002/hed.23609. [Epub ahead of print]

PMID:
24431011
[PubMed - as supplied by publisher]
16.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1198-205. doi: 10.1016/j.ijrobp.2012.05.008. Epub 2012 Jun 30.

PMID:
22749632
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.

Suntharalingam M, Haas ML, Van Echo DA, Haddad R, Jacobs MC, Levy S, Gray WC, Ord RA, Conley BA.

Cancer. 2001 Feb 1;91(3):548-54.

PMID:
11169937
[PubMed - indexed for MEDLINE]
18.

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.

Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C.

BMC Cancer. 2013 Feb 22;13:84. doi: 10.1186/1471-2407-13-84.

PMID:
23433435
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.

Kiyota N, Tahara M, Okano S, Kawashima M, Matsuura K, Onozawa Y, Nibu K, Hayashi R, Yoshimura K, Ohtsu A.

Jpn J Clin Oncol. 2012 Oct;42(10):927-33. Epub 2012 Aug 23.

PMID:
22923484
[PubMed - indexed for MEDLINE]
Free Article
20.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.

Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e237-43. doi: 10.1016/j.ijrobp.2011.03.043. Epub 2011 May 27.

PMID:
21620580
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk